225 related articles for article (PubMed ID: 30384036)
1. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.
Huang Y; Long Y; Deng D; Liu Z; Liang H; Sun N; Xu Y; Lai Y; Cheng P
Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036
[TBL] [Abstract][Full Text] [Related]
2. Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia.
Del Vecchio GC; Nigro A; Giordano P; Schettini F; Altomare M; Pietrapertosa A; De Mattia D
Acta Haematol; 2007; 118(3):136-40. PubMed ID: 17804900
[TBL] [Abstract][Full Text] [Related]
3. Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin.
Teli A; Economou M; Rudolf J; Tzovaras F; Gourtsa V; Kondou A; Kontopoulos E; Gombakis N; Athanassiou-Metaxa M; Zafeiriou D
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):195-202. PubMed ID: 22322135
[TBL] [Abstract][Full Text] [Related]
4. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels.
Hemmer CJ; Kern P; Holst FG; Radtke KP; Egbring R; Bierhaus A; Nawroth PP; Dietrich M
Am J Med; 1991 Jul; 91(1):37-44. PubMed ID: 1858827
[TBL] [Abstract][Full Text] [Related]
5. Hypercoagulable state in five thalassemia intermedia patients.
Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
[TBL] [Abstract][Full Text] [Related]
6. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
Abdulwahid DA; Hassan MK
Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
[TBL] [Abstract][Full Text] [Related]
7. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status.
Natesirinilkul R; Charoenkwan P; Nawarawong W; Boonsri S; Tantivate P; Wongjaikum S; Manowong S; Sanguansermsri T
Thromb Res; 2016 Apr; 140():125-131. PubMed ID: 26971311
[TBL] [Abstract][Full Text] [Related]
8. [Significance of Tissue Factor-Bearing Microparticle Procoagulation Activity and Antithrombin Ⅲ Detection in Thalassemia Patients].
Su X; Liu H; Sun N; Cheng P; Deng DH; Long Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):539-544. PubMed ID: 30998167
[TBL] [Abstract][Full Text] [Related]
9. Normal hemostatic parameters in children and young adults with α-thalassemia diseases.
Sirachainan N; Chuansumrit A; Kadegasem P; Sasanakul W; Wongwerawattanakoon P; Mahaklan L
Thromb Res; 2016 Oct; 146():35-42. PubMed ID: 27572718
[TBL] [Abstract][Full Text] [Related]
10. Protein C and antithrombin III in polytransfused thalassemic patients.
Musumeci S; Leonardi S; Di Dio R; Fischer A; Di Costa G
Acta Haematol; 1987; 77(1):30-3. PubMed ID: 3107318
[TBL] [Abstract][Full Text] [Related]
11. Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.
Zahedpanah M; Azarkeivan A; Aghaieepour M; Nikogoftar M; Ahmadinegad M; Hajibeigi B; Tabatabaiee MR; Maghsudlu M
Hematology; 2014 Dec; 19(8):472-6. PubMed ID: 24620948
[TBL] [Abstract][Full Text] [Related]
12. Changes of hemostatic factors in patients with hemoglobinopathies.
Oner AF; Gürgey A; Okur H; Kirazli S; Gümrük F; Altay C
Turk J Pediatr; 1999; 41(3):323-7. PubMed ID: 10770092
[TBL] [Abstract][Full Text] [Related]
13. Elevations of Thrombotic Biomarkers in Hemoglobin H Disease.
Chansai S; Fucharoen S; Fucharoen G; Jetsrisuparb A; Chumpia W
Acta Haematol; 2018; 139(1):47-51. PubMed ID: 29402840
[TBL] [Abstract][Full Text] [Related]
14. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.
Simioni P; Morboeuf O; Tognin G; Gavasso S; Tormene D; Woodhams B; Pagnan A
Thromb Res; 2006; 117(5):523-8. PubMed ID: 15921724
[TBL] [Abstract][Full Text] [Related]
15. Thrombin Activable Fibrinolysis Inhibitor in Beta Thalassemia.
Chhikara A; Sharma S; Chandra J; Nangia A
Indian J Pediatr; 2017 Jan; 84(1):25-30. PubMed ID: 27487812
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of hematological characteristics on the 79 co-inheritance of α-thalassemia and β-thalassemia carriers in Guangxi].
Xiong F; Lou JW; Wei XF; Sun MN; Huang JW; Shang X; Zhang XH; Xu XM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):856-60. PubMed ID: 23384911
[TBL] [Abstract][Full Text] [Related]
17. Thalassemia major-- on the verge of bleeding or thrombosis?
Naithani R; Chandra J; Narayan S; Sharma S; Singh V
Hematology; 2006 Feb; 11(1):57-61. PubMed ID: 16522552
[TBL] [Abstract][Full Text] [Related]
18. A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease).
Ekwattanakit S; Siritanaratkul N; Viprakasit V
Am J Hematol; 2018 May; 93(5):623-629. PubMed ID: 29359464
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
Haghpanah S; Vahdati S; Karimi M
Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
[TBL] [Abstract][Full Text] [Related]
20. Protein C levels in beta-thalassemia major patients in the east Nile delta of Egypt.
Hassan TH; Elbehedy RM; Youssef DM; Amr GE
Hematol Oncol Stem Cell Ther; 2010; 3(2):60-5. PubMed ID: 20543538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
